2009
DOI: 10.1016/j.jchromb.2009.01.021
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous determination of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol in rat plasma by liquid chromatography–mass spectrometry: Application to pharmacokinetics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
78
1
1

Year Published

2009
2009
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(81 citation statements)
references
References 24 publications
(21 reference statements)
1
78
1
1
Order By: Relevance
“…Along with our collaborators, we have reported that [6]-shogaol was more effective than [6]-gingerol in inhibiting 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mice (Wu et al, 2010). Furthermore, Dugasani et al (2010) The pharmacokinetics of [6]-shogaol in mice and in humans have been investigated (Zick et al, 2008(Zick et al, , 2010Wang et al, 2009;Asami et al, 2010;Iwabu et al, 2010). Yu et al (2007) reported that free [6]-shogaol and glucuronidated and sulfated metabolites of [6]-shogaol were detected in the plasma with peak concentrations of 13.6 Ϯ 6.9 ng/ml, 0.73 Ϯ 0.54 g/ml, and 0.047 Ϯ 0.035 g/ml, respectively, 1 h after oral administration of 2.0 g of ginger extracts (containing 45.04 mg of [6]-shogaol) in humans.…”
Section: Introductionmentioning
confidence: 97%
See 1 more Smart Citation
“…Along with our collaborators, we have reported that [6]-shogaol was more effective than [6]-gingerol in inhibiting 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mice (Wu et al, 2010). Furthermore, Dugasani et al (2010) The pharmacokinetics of [6]-shogaol in mice and in humans have been investigated (Zick et al, 2008(Zick et al, , 2010Wang et al, 2009;Asami et al, 2010;Iwabu et al, 2010). Yu et al (2007) reported that free [6]-shogaol and glucuronidated and sulfated metabolites of [6]-shogaol were detected in the plasma with peak concentrations of 13.6 Ϯ 6.9 ng/ml, 0.73 Ϯ 0.54 g/ml, and 0.047 Ϯ 0.035 g/ml, respectively, 1 h after oral administration of 2.0 g of ginger extracts (containing 45.04 mg of [6]-shogaol) in humans.…”
Section: Introductionmentioning
confidence: 97%
“…), a member of the Zingiberaceae family, has been cultivated for thousands of years as a spice and for medicinal purposes. Ginger has received extensive attention because of its antioxidant, anti-inflammatory, and anticancer activities (Kawai et al, 1994;Surh, 2002;Shukla and Singh, 2007;Zick et al, 2008;Wang et al, 2009). The major pharmacologically active components of ginger are gingerols and shogaols (Masada et al, 1974;Jiang et al, 2005Jiang et al, , 2006Jiang et al, , 2007Yu et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…The antioxidative, anti-inflammatory, and antitumor properties of ginger (Zingiber officinale Roscoe, Zingiberaceae) have been reported in previous studies (1)(2)(3)(4)(5). Various clinical trials have evaluated ginger extracts to decrease lipid levels (6), treat arthritis (7,8), prevent nausea and vomiting (9)(10)(11), and reduce pain in women with primary dysmenorrhea (12).…”
Section: Introductionmentioning
confidence: 99%
“…It has been used since antiquity for its health benefits (13). Extracts obtained from its roots usually contain polyphenol compounds, such as [6]-gingerol, [8]gingerol, and [10]-gingerol, which have been cited as the main components responsible for its pharmacological effects (14,15). Among other potential mechanisms, ginger has antioxidant (15)(16)(17) and anti-inflammatory properties (15,18,19).…”
mentioning
confidence: 99%